SEC Company Response from EvoNexus Group (EVON) — Sep 24, 2025
EvoNexus Group LTD
Date: Sept. 24, 2025 · CIK: 0002075036 · Accession: 0001185185-25-001278
AI Filing Summary & Sentiment
File numbers found in text: 333-290099
Referenced dates: September 17, 2025
Letter
Via EDGAR Division of Corporation Finance Office of Technology Attention: Joseph Cascarano Re: EvoNexus Group LTD Registration Statement on Form F-1 Filed September 8, 2025 File No. 333-290099
Dear sirs and madams:
This letter is in response to the letter dated September 17, 2025, from the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “Commission”) addressed to EvoNexus Group LTD (the “Company,” “we,” and “our”). For ease of reference, we have recited the Commission’s comment in this response. Amendment No. 1 to Registration Statement on Form F-1 (the “Amendment No. 1”) is being publicly filed to accompany this letter.
Registration Statement on Form F-1
Risk Factors
If we cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of Nasdaq..., page 39
1. We note that Nasdaq recently proposed a new rule that would require companies principally operating in China, including Hong Kong and Macau, to raise at least $25 million in an initial public offering to list on Nasdaq. Please revise your risk factor to address the potential effects this proposal could have on your ability to list and maintain a listing on the Nasdaq Capital Market Exchange.
Response: In response to the Staff’s comments, we have amended our disclosure on page 39 of the Amendment No. 1 accordingly.
We appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel, Ying Li, Esq., of Hunter Taubman Fischer & Li LLC, at (212) 530-2206.
Very
truly yours,
/s/
Chong Li
Show Raw Text
CORRESP
1
filename1.htm
EvoNexus
Group LTD
September
24, 2025
Via
EDGAR
Division
of Corporation Finance
Office
of Technology
U.S.
Securities and Exchange Commission
100
F Street, NE
Washington,
D.C., 20549
Attention:
Joseph
Cascarano
Robert
Littlepage
Alexandra Barone
Jan Woo
Re:
EvoNexus
Group LTD
Registration
Statement on Form F-1
Filed
September 8, 2025
File
No. 333-290099
Dear
sirs and madams:
This
letter is in response to the letter dated September 17, 2025, from the staff (the “Staff”) of the U.S. Securities and Exchange
Commission (the “Commission”) addressed to EvoNexus Group LTD (the “Company,” “we,” and “our”).
For ease of reference, we have recited the Commission’s comment in this response. Amendment No. 1 to Registration Statement on
Form F-1 (the “Amendment No. 1”) is being publicly filed to accompany this letter.
Registration
Statement on Form F-1
Risk
Factors
If
we cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of Nasdaq..., page 39
1.
We note that Nasdaq recently proposed a new rule that would require companies principally operating in China, including Hong Kong and
Macau, to raise at least $25 million in an initial public offering to list on Nasdaq. Please revise your risk factor to address the potential
effects this proposal could have on your ability to list and maintain a listing on the Nasdaq Capital Market Exchange.
Response:
In response to the Staff’s comments, we have amended our disclosure on page 39 of the Amendment No. 1 accordingly.
We
appreciate the assistance the Staff has provided with its comments. If you have any questions, please do not hesitate to call our counsel,
Ying Li, Esq., of Hunter Taubman Fischer & Li LLC, at (212) 530-2206.
Very
truly yours,
/s/
Chong Li
Name:
Chong
Li
Title:
Chief
Executive Officer
cc:
Ying
Li, Esq.
Hunter
Taubman Fischer & Li LLC